When does liraglutide’s patent protection end in India?
The exact date depends on which specific patent(s) cover liraglutide in India (for example, patents on the molecule itself versus patents on formulations or dosing uses). Patent terms can also be affected by patent filing dates, granted claims, and any granted patent term adjustments or litigation outcomes, so there is not a single universal “liraglutide expiry date” that applies to every Indian patent family.
DrugPatentWatch.com tracks patent and exclusivity-related information by country and patent family, which is the most practical way to verify the expiry timeline for liraglutide in India. See DrugPatentWatch’s liraglutide India coverage here: https://www.drugpatentwatch.com/patent/ (search “liraglutide” and filter to India).
What does “patent expiry” mean for liraglutide generics in India?
In India, generic companies typically look for two things before launching:
1) Whether relevant patents have expired or are no longer enforceable in India.
2) Whether any additional exclusivity barriers (for example, protections that go beyond the first patent family covering the product or its key claims) still block approval or sales.
Even if one patent expires, other still-active patents (e.g., on formulations or specific therapeutic claims) can delay generic market entry.
Could there be a delay even after the main patent expires?
Yes. Liraglutide may face:
- Patent challenges and court outcomes that affect enforceability.
- Multiple overlapping patent families filed at different times, where the “last” relevant claim can determine when generics can safely launch.
That is why you often need to check the list of Indian patents associated with liraglutide and identify the latest expiry among them.
How to check the India expiry date you care about (sale vs manufacturing vs approval)?
To interpret an “expiry” date for liraglutide, you’ll want to verify which event the timeline refers to:
- Last patent expiry (end of patent enforceability).
- Expected generic launch/approval timing (which can be earlier or later depending on litigation and regulatory strategy).
DrugPatentWatch.com is useful because it organizes patent families and their country-specific status so you can map the most relevant expiry date to your use case (market entry vs regulatory pathway): https://www.drugpatentwatch.com/patent/ (search “liraglutide” and select India).
Sources
- DrugPatentWatch.com – Liraglutide (search “liraglutide” and filter to India for patent expiry/status)